NF-kappaB--a potential therapeutic target for inhibition of human cytomegalovirus (re)activation? (Q52954259)

9 May 2018

title

NF-kappaB--a potential therapeutic target for inhibition of human cytomegalovirus (re)activation? (English)

1 reference

9 May 2018

0 references

0 references

4

Hans-Dieter Volk

1 reference

9 May 2018

author name string

Susanna Prösch

series ordinal

1

1 reference

9 May 2018

Regine Wuttke

series ordinal

2

1 reference

9 May 2018

Detlev H Krüger

series ordinal

3

1 reference

9 May 2018

publication date

1 October 2002

1 reference

9 May 2018

published in

Biological Chemistry

1 reference

9 May 2018

volume

383

1 reference

9 May 2018

page(s)

1601-1609

1 reference

9 May 2018

issue

10

1 reference

9 May 2018

A high prevalence of cytomegalovirus antigenaemia in patients with moderate to severe chronic plaque psoriasis: an association with systemic tumour necrosis factor alpha overexpression.

cites work

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

The NF-kappa B and I kappa B proteins: new discoveries and insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

Cytomegalovirus induction of interleukin-6 in lung fibroblasts occurs independently of active infection and involves a G protein and the transcription factor, NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

In vitro inhibition of human cytomegalovirus replication by calcium trinatrium diethylenetriaminepentaacetic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

Cytomegalovirus reactivation and tumour necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

Not just research tools--proteasome inhibitors offer therapeutic promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

Infection in organ-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

High incidence of active cytomegalovirus infection among septic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

The human cytomegalovirus major immediate-early distal enhancer region is required for efficient viral replication and immediate-early gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

A deletion mutant in the human cytomegalovirus gene encoding IE1(491aa) is replication defective due to a failure in autoregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFalpha is mediated via induction of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

A novel link between stress and human cytomegalovirus (HCMV) infection: sympathetic hyperactivity stimulates HCMV activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

CCAAT/enhancer-binding proteins alpha and beta negatively influence the capacity of tumor necrosis factor alpha to up-regulate the human cytomegalovirus IE1/2 enhancer/promoter by nuclear factor kappaB during monocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

Inhibition of cytomegalovirus immediate early gene expression: a therapeutic option?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

Cell type-specific induction of the major immediate early enhancer of human cytomegalovirus by cyclic AMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

Tumour necrosis factor alpha stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

IkappaB kinase: beginning, not the end

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

Human cytomegalovirus latency-associated protein pORF94 is dispensable for productive and latent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

In vitro inhibition of human cytomegalovirus replication in human foreskin fibroblasts and endothelial cells by ascorbic acid 2-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.181

21 January 2018

Identifiers

DOI

10.1515/BC.2002.181

1 reference

9 May 2018

PubMed ID

12452437

1 reference

9 May 2018